(3-Bromopyridin-4-yl)methanamine dihydrochloride is primarily used in pharmaceutical research and development as a key intermediate in the synthesis of various bioactive compounds. It plays a significant role in the creation of molecules targeting neurological disorders, particularly those involving modulation of neurotransmitter systems. Additionally, it is utilized in the development of potential anticancer agents, where its structure contributes to the inhibition of specific enzymes or receptors involved in tumor growth. This compound is also explored in the field of medicinal chemistry for designing novel drugs with improved efficacy and selectivity. Its application extends to organic synthesis, where it serves as a building block for constructing complex heterocyclic compounds with potential therapeutic properties.